SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

GLENMARK PHARMACEUTICALS

BSE: 532296 09 Sep 2025
Healthcare
₹ 1993.15
Glenmark Pharmaceuticals ltd specializes in Pharmaceuticals within the Healthcare sector.

GLENMARK PHARMACEUTICALS - Share Price & Details

Market Cap
₹59,708
High /Low
2,286 / 1,275
Stock P/E
44.8
Book Value
₹314.0
Dividend Yield
0.12
ROCE
19.4
ROE
₹15.8
Face Value
1.0
PEG Ratio
7.17
EVEBITDA
₹24.7
Debt
2,473
CMP / FCF
-67.3
Debt to equity
₹0.28
NP Ann
1,047
High price all time
2,286
Piotroski score
₹6.0
Graham Number
434.0
No. Eq. Shares
28.2
Net CF
₹17.4
Net profit
754
Price to book value
6.69
Interest Coverage
₹8.66
Low price all time
109.0
Industry PE
33.4
Reserves
₹8,821
Free Cash Flow
₹-1,575

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.4691.0
Triochem Products Ltd.,NANANANA0
GLENMARK PHARMACEUTICALS LTD.24642.633302.2623949.2811.759,70844.8
BIOCON LTD.5984.0-83.05371.0-0.0748746135.0
Laurus Labs Limited14542.71579.414327.52.934832595.0

Peer Comparison Chart


About GLENMARK PHARMACEUTICALS

Glenmark Pharmaceuticals ltd, with Security Code 532296, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Glenmark’s Workforce Strategy: 14,989 employees, 4.9 lakh training hours, 33% women on Board

(29 Aug 2025)
Glenmark Pharmaceuticals focuses on employee growth with extensive training hours, a commitment to women's representation on its board,...
Read more →

Five Stocks To Buy Today: Glenmark Pharma, Bharti Airtel, Others—Check Target Price

(26 Aug 2025)
Five Stocks To Buy Today: Stock market experts recommended five stocks for trade on Tuesday that promise returns for investors.
Read more →

Glenmark, Alembic Pharma, Sun Pharma recall products in US: USFDA

(23 Aug 2025)
Glenmark, Alembic Pharmaceuticals, and Sun Pharma are recalling various products in the US due to manufacturing issues, according to the USFDA.
Read more →

Glenmark Pharma shares fall 4% as Q1 earnings show fails to impress

(23 Aug 2025)
Glenmark Pharmaceuticals shares fell up to 4 percent in trade on August 18, after the pharma player's earnings show for the June quarter...
Read more →

Glenmark Pharma Q1 Net Profit Falls 86% YoY to ₹47 Crore

(23 Aug 2025)
Glenmark Pharmaceuticals reported a sharp 86.2% year-on-year decline in net profit for the June quarter of FY26, with profit falling to...
Read more →

Buy Glenmark Pharma; target of Rs 2400: Motilal Oswal

(22 Aug 2025)
Motilal Oswal is bullish on Glenmark Pharma has recommended buy rating on the stock with a target price of Rs 2400 in its research report...
Read more →

Company Updates